Holen Sie sich die Stockscreener-App
14.09
0.03%
0.0047
Handel nachbörslich:
14.28
0.1903
+1.35%
Apollomics Inc Aktie (APLM) Neueste Nachrichten
Apollomics Warrants (APLMW) Hold at $0.01 After Modest Gain – Tight Trading Range PersistsCommunity Buy Alerts - Newser
APLM SEC FilingsAPOLLOMICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
APLMW Technical Analysis | Trend, Signals & Chart Patterns | APOLLOMICS INC-27 (NASDAQ:APLMW) - ChartMill
Apollomics Inc. (APLMW) Warrants Trade at $0.01 After Double-Digit DeclineSell Signal Alerts - Newser
Apollomics (APLM) director converts 500 RSUs into Class A shares - Stock Titan
How (APLM) Movements Inform Risk Allocation Models - Stock Traders Daily
Apollomics (APLMW) Stock Analysis Report | Financials & Insights - Benzinga España
Apollomics Inc. (APLM) files F-3/A to register 279,775 Class A shares - Stock Titan
Is Apollomics (APLM) Still a Buy After +10.29% Rally? 2026-05-15Investment Picks - newser.com
Apollomics (APLM) Climbs +0.54% — Resistance at $14.28 in Focus 2026-05-14Social Buy Zones - newser.com
TradingKey - TradingKey
What to expect when Apollomics (APLMW) reports earnings |AI Powered Stock Picks - Newser
Trading Systems Reacting to (APLM) Volatility - Stock Traders Daily
The labor dynamics in Apollomics (APLM) results |Inventory Turnover - newser.com
APLMW | Apollomics Inc. Warrant Insider Trading - Quiver Quantitative
Is Apollomics (APLMW) dividend sustainable? (Smart Money Exits) 2026-04-29Expert Verified Trades - newser.com
Apollomics (Nasdaq: APLM) slashes 2025 loss amid cost cuts and new vebreltinib deal revenue - Stock Titan
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress - marketscreener.com
How Apollomics Inc. (APLM) Affects Rotational Strategy Timing - Stock Traders Daily
Over 282 subjects enrolled as Apollomics targets 2027 U.S. filing - Stock Titan
APLM Apollomics highlights oncology pipeline progress and upcoming clinical trial milestones in its latest quarterly earnings report.Gamma Squeeze - Newser
APLM: Strategic restructuring and licensing revenue reduced losses, but liquidity and going concern risks persist - TradingView
Apollomics (NASDAQ: APLM) warns on going concern, defers vebreltinib NDA and writes down asset - Stock Titan
Apollomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
APLM Forecast — Price Target — Prediction for 2027 - TradingView
Apollomics Inc. Warrant (APLMW) - Minichart
Apollomics (APLM) Stock: Is It a Smart Investment (Slight Loss) 2026-04-18Crowd Entry Signals - Cổng thông tin điện tử tỉnh Lào Cai
Hong Jung Chen Net Worth (2026) - GuruFocus
Ya Chi Huang Net Worth (2026) - GuruFocus
Peter Kuan How Lin Net Worth (2026) - GuruFocus
Yi Kuei Chen Net Worth (2026) - GuruFocus
Chen Huan Jan Net Worth (2026) - GuruFocus
Hsien Shu Tsai Net Worth (2026) - GuruFocus
Apollomics (APLM) director details RSUs, options and warrants in Form 3/A - Stock Titan
Apollomics (APLM) CFO has shares withheld for RSU tax obligations - Stock Titan
(APLM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
[Form 3/A] Apollomics Inc. Amended Initial Statement of Beneficial Ownership - Stock Titan
Apollomics (APLM) director Jan Chen-Huan reports 1,000 RSUs and 1,000 shares - Stock Titan
Apollomics (APLM) CFO details 20,000 RSUs and 15,900 shares in Form 3/A - Stock Titan
Apollomics (ticker: APLM) CEO details direct and indirect share stakes - Stock Titan
Apollomics (APLM) director discloses 1,000 restricted stock units award - Stock Titan
Apollomics (APLM) COO details RSU grants and Maxpro warrant stakes - Stock Titan
Apollomics (APLM) director Huang Ya-Chi details RSU vesting and share holdings - Stock Titan
Tech Rally: Does Apollomics Inc Equity Warrant have pricing power2026 PreEarnings & Fast Entry Momentum Alerts - baoquankhu1.vn
Market Outlook: Is Apollomics Inc in a consolidation phase2026 Bull vs Bear & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Bear Alert: Can Apollomics Inc stock outperform in a bear marketWeekly Stock Analysis & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Bond Watch: Can Apollomics Inc Equity Warrant expand its profit marginsEarnings Miss & Smart Swing Trading Techniques - baoquankhu1.vn
Aug Wrap: Will Apollomics Inc Equity Warrant outperform the market in YEARJobs Report & Long Hold Capital Preservation Tips - baoquankhu1.vn
Risk Off: Is Apollomics Inc attractive at current valuation2026 Analyst Calls & Long-Term Capital Growth Ideas - baoquankhu1.vn
What happens to Apollomics (APLM) Stock after earnings | Price at $15.10, Up 1.68%Debt Free Companies - Newser
Apollomics, Inc. (APLM) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Yi-Kuei Chen Discloses Investment at Apollomics Inc. with 5.3% Stake - TradingView
Apollomics (APLM) COO Yi-Kuei Chen discloses 5.3% ownership stake in latest filing - Stock Titan
Aug PostEarnings: Is Apollomics Inc subject to activist investor interestWeekly Trend Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Is Apollomics (APLM) Stock Safe to Buy Now | Price at $15.30, Up 4.44%Community Driven Stock Picks - UBND thành phố Hải Phòng
Growth Review: Is Apollomics Inc subject to activist investor interest2026 Market WrapUp & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Apollomics (APLM) chair reports 41.8% stake and $2M convertible bridge loan - Stock Titan
APLM Stock Analysis: Apollomics Inc stays at 14.72 amid zero daily price change - Newser
Apollomics secures $2M convertible note from CEO Chen By Investing.com - Investing.com South Africa
Apollomics Inc. Secures $2 Million Bridge Financing to Support Biotechnology Initiatives - geneonline.com
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):